Association between prednisone doses received during the first and subsequent 11 months of follow-up after the diagnosis of systemic lupus erythematosus
| Prednisone-2–12 | ||||
|---|---|---|---|---|
| Prednisone-1 | No | Low | Medium | High |
| No (n=113) | 79 (70%) | 20 (18%) | 14 (12%) | 0 (0%) |
| Low (n=24) | 1 (4%) | 19 (79%) | 4 (17%) | 0 (0%) |
| Medium (n=46) | 2 (4%) | 19 (41%) | 25 (54%) | 0 (0%) |
| High (n=40) | 0 (0%) | 10 (25%) | 25 (62%) | 5 (13%) |
Prednisone-1: average prednisone dose during the first month.
Prednisone-2–12: average prednisone dose during months 2–12.